Eosinophilic Bronchitis
📧 Sign up to get email alerts when something new happens for Eosinophilic Bronchitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Mepolizumab for the Treatment of Chronic Cough With Eosinophilic Airways Diseases [Phase 4]
Phase 4 trial evaluating mepolizumab for chronic cough associated with eosinophilic airway diseases has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2019-06-05Clinical Trial Update: Therapeutic Effect of Different Treatment Course With Inhaled Corticosteroids in Eosinophilic Bronchitis Patients [Phase 4]
Phase 4 trial updating the therapeutic effect of different inhaled corticosteroid treatment courses in eosinophilic bronchitis patients.
-
CLINICAL_TRIALS trial_result · 2018-04-04Clinical Trial Update: Study of the Steroid Sparing Effect of Xolair (Omalizumab) in Patients With Persistent Eosinophilic Bronchitis [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating the steroid-sparing effect of omalizumab (Xolair) in patients with eosinophilic bronchitis a…
-
CLINICAL_TRIALS trial_result · 2018-04-04Clinical Trial Update: Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma [Phase 2, Phase 3]
A Phase 2/3 trial of an anti-IL-5 monoclonal antibody for prednisone-dependent eosinophilic asthma has completed.
-
CLINICAL_TRIALS research · 2015-09-21Clinical Trial Update: Gene Expression Profile and Inflammation Profile of Classic Asthma, Cough Variant Asthma and Eosinophilic Bronchitis
This clinical trial update describes a study investigating gene expression and inflammation profiles in classic asthma, cough-variant asthma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-06Clinical Trial Update: The Effect of Bronchodilator on Eosinophilic Bronchitis and Cough Variant Asthma [Phase 4]
An ongoing Phase 4 clinical trial is investigating the effect of a bronchodilator on eosinophilic bronchitis and cough-variant asthma.